Phase II Stage Of Pivotal Clinical Trial Of KX-826 Tincture 1.0% For The Treatment Of Male Adult Aga In China Reached Primary Endpoint
07.08.2025 - 18:05:38 | prnewswire.co.uk
View original content:https://www.prnewswire.co.uk/news-releases/phase-ii-stage-of-pivotal-clinical-trial-of-kx-826-tincture-1-0-for-the-treatment-of-male-adult-aga-in-china-reached-primary-endpoint-302513822.html
en | boerse | 67967900 |
